Lensar Inc Stock Today
| LNSR Stock | USD 15.13 0.53 3.63% |
PerformanceSolid
| Odds Of DistressLow
|
LENSAR is selling at 15.13 as of the 17th of March 2025; that is 3.63 percent increase since the beginning of the trading day. The stock's lowest day price was 14.87. LENSAR has less than a 14 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 2nd of October 2020 | Category Healthcare | Classification Health Care |
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida. The company has 11.79 M outstanding shares of which 63.32 K shares are now shorted by private and institutional investors with about 1.0 trading days to cover. More on LENSAR Inc
Moving together with LENSAR Stock
Moving against LENSAR Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
LENSAR Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Nicholas Curtis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Drugs (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsLENSAR can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand LENSAR's financial leverage. It provides some insight into what part of LENSAR's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LENSAR Inc (LNSR) is traded on NASDAQ Exchange in USA. It is located in 2800 Discovery Drive, Orlando, FL, United States, 32826 and employs 140 people. LENSAR is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 178.38 M. LENSAR Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 11.79 M outstanding shares of which 63.32 K shares are now shorted by private and institutional investors with about 1.0 trading days to cover.
LENSAR Inc currently holds about 25.2 M in cash with (2.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.29.
Check LENSAR Probability Of Bankruptcy
Ownership AllocationThe market capitalization of LENSAR Inc is $178.38 Million. LENSAR Inc holds substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check LENSAR Ownership Details
LENSAR Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Essex Investment Management Company, Llc | 2024-12-31 | 39.9 K | |
| State Street Corp | 2024-12-31 | 39.4 K | |
| Bank Of America Corp | 2024-12-31 | 27.7 K | |
| Atria Investments Llc | 2024-12-31 | 26.1 K | |
| Bailard Inc | 2024-12-31 | 20.3 K | |
| Northern Trust Corp | 2024-12-31 | 20 K | |
| Sanctuary Advisors, Llc | 2024-12-31 | 19.5 K | |
| Evernest Financial Advisors Llc | 2024-12-31 | 19.5 K | |
| Nuveen Asset Management, Llc | 2024-12-31 | 17.9 K | |
| Park West Asset Management Llc | 2024-12-31 | 810.7 K | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 614.4 K |
LENSAR Historical Income Statement
LENSAR Stock Against Markets
LENSAR Corporate Executives
Elected by the shareholders, the LENSAR's board of directors comprises two types of representatives: LENSAR inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LENSAR. The board's role is to monitor LENSAR's management team and ensure that shareholders' interests are well served. LENSAR's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LENSAR's outside directors are responsible for providing unbiased perspectives on the board's policies.
Additional Tools for LENSAR Stock Analysis
When running LENSAR's price analysis, check to measure LENSAR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENSAR is operating at the current time. Most of LENSAR's value examination focuses on studying past and present price action to predict the probability of LENSAR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENSAR's price. Additionally, you may evaluate how the addition of LENSAR to your portfolios can decrease your overall portfolio volatility.